NEW DELHI: The Centre has proposed amending drug rules to stop repeating virus tests on medicines made from human plasma, saying the raw plasma used to produce these products is already screened for infections such as HIV and hepatitis before manufacturing begins.These medicines include albumin, intravenous immunoglobulin (IVIG), and clotting factors such as Factor VIII and Factor IX, which are used to treat immune disorders, severe infections and bleeding conditions such as haemophilia.Officials said the move aims to align India’s drug regulations with international pharmacopoeia standards. Global guidelines require pooled plasma to be tested for hepatitis B surface antigen, hepatitis C virus RNA and HIV antibodies before it is used for fractionation, and only plasma that tests negative is cleared for manufacturing plasma-derived medicines.Israel Iran WarUS-Israel-Iran War News Live Updates: Saudi intercepts drone headed to Shaybah oil field; Israeli strikes 10 Hezbollah targets in Beirut’Legitimate targets’: Iran issues warning to US tech firms including Google, Amazon, Microsoft, NvidiaSafe Passage For Indian Vessels: Iran clears Indian-flagged ships in Hormuz; US, Europe, Israel face curbsCurrently, plasma collected for manufacturing these medicines is first pooled and tested for viruses, including HIV, hepatitis B and hepatitis C. However, once medicines are produced from this screened plasma, the finished products are again tested for the same viral markers under existing rules. The government now proposes to remove this second round of testing.The health ministry has issued a draft notification seeking public comments on amendments to the Drugs Rules, 1945, which regulate the testing of blood-derived products. Dr Aseem Kumar Tiwari, Senior Director, Department of Transfusion Medicine, Medanta, Gurugram, said that surplus plasma collected from blood donors may be used by plasma fractionators to manufacture several life-saving medicines.“Plasma-derived medicinal products (PDMP) such as albumin, intravenous immunoglobulin (IVIG), and clotting factors like Factor VIII and Factor IX are widely used to treat immune disorders, severe infections and bleeding conditions such as haemophilia,” he said.He added that blood centres often generate surplus plasma after meeting patient needs, which can be supplied to specialised fractionation facilities where different proteins are separated to manufacture these medicines.Dr Tiwari said PDMPs undergo multiple safety checks before reaching patients. “Donated plasma is screened for infections such as HIV, hepatitis B, hepatitis C, malaria, and syphilis, and the manufacturing process includes viral inactivation steps to ensure safety,” he said.“These medicines, known globally as plasma-derived medicinal products, have not been linked to infection transmission because of stringent testing and viral inactivation during manufacturing,” he added.Officials say repeating the same viral tests at the finished product stage creates duplication not required under global practices. The proposed amendment seeks to rationalise testing requirements while maintaining strict safety checks at the plasma screening stage.The draft rules were issued after consultation with the Drugs Technical Advisory Board, and stakeholders have been given 30 days to submit comments before the amendment is finalised.About the AuthorAnuja JaiswalAnuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.Read MoreEnd of ArticleFollow Us On Social MediaVideos“Energy Security Compromised”: Rahul Gandhi Sounds Alarm In Parliament’India’s Fuel Supply Stable’: Hardeep Singh Puri Rejects LPG Shortage, Oil Crisis Fears In Lok Sabha’I Heard A Cracker Sound…’: Farooq Abdullah Opens Up About Assassination AttemptRahul Gandhi Warns Of Fuel Crisis Amid Middle East Conflict, BJP MP Dubey Hits Back With Soros JibeAmid US-Iran War, First Crude Tanker Shenlong Safely Reaches Mumbai Port Through Strait Of HormuzIndian Ship Safety To Energy Crisis: MEA Reveals Details On Talks Between Jaishankar And Iran FM’Farooq’s Killing Intention Of Govt?’: Kharge Asks In Parl; Nadda Hits Back, Slams ‘Politics’Mahakumbh Girl Monalisa Marries Farman Khan In Kerala, Rejects Love Jihad Charges Amid Family RowIran Breaks Silence After Reports Claim Tehran Allowed Indian Oil Tanker Through Strait Of Hormuz’I Have Always Tried To…’: LS Speaker Om Birla’s First Remarks After No-Confidence Motion Fails123PhotostoriesNormal cholesterol but early heart attack risk? Doctors say Lipoprotein(a) test can reveal hidden danger6 superbikes famous for their thrilling engine roarAhead of ‘Dhurandhar: The Revenge’ release, revisiting Ranveer Singh’s iconic characters like Khilji, Bajirao, Rocky Randhawa9 effective ways to fix excess salt in curries and sabziWhatsApp launches parent-managed accounts for pre-teens: Step-by-step guide to control contacts, privacy, and group access safely8 rattlesnake facts that explain how these venomous snakes hunt, strike and surviveMemory loss in your 40s may signal early-onset Dementia: Doctors explain symptoms, causes, and prevention tips6 common rental scams and how to avoid them7 signs you are forcing a dead relationshipHow to make Bread Paneer Pakoda for evening snacking with chai123Hot PicksStrait of Hormuz naval minesChina Yj-12 missileUCC gender biasCovid vaccine compensation policyIncome Tax CalculatorPublic holidays March 2026Bank Holidays MarchTop TrendingCardi BIPL Teams Match ScheduleThe RockMumbai TemperatureLPG Shortage in MumbaiMadhya Pradesh Student RapeIransoleimani class warshipsIran US WarReliance Oil Refinery in USMiddle East War
NEW DELHI: The Centre has proposed amending drug rules to stop repeating virus tests on medicines made from human plasma, saying the raw plasma used to produce these products is already screened for infections such as HIV and hepatitis before manufacturing begins.These medicines include albumin, intravenous immunoglobulin (IVIG), and clotting factors such as Factor VIII and Factor IX, which are used to treat immune disorders, severe infections and bleeding conditions such as haemophilia.Officials said the move aims to align India’s drug regulations with international pharmacopoeia standards. Global guidelines require pooled plasma to be tested for hepatitis B surface antigen, hepatitis C virus RNA and HIV antibodies before it is used for fractionation, and only plasma that tests negative is cleared for manufacturing plasma-derived medicines.Currently, plasma collected for manufacturing these medicines is first pooled and tested for viruses, including HIV, hepatitis B and hepatitis C. However, once medicines are produced from this screened plasma, the finished products are again tested for the same viral markers under existing rules. The government now proposes to remove this second round of testing.The health ministry has issued a draft notification seeking public comments on amendments to the Drugs Rules, 1945, which regulate the testing of blood-derived products. Dr Aseem Kumar Tiwari, Senior Director, Department of Transfusion Medicine, Medanta, Gurugram, said that surplus plasma collected from blood donors may be used by plasma fractionators to manufacture several life-saving medicines.“Plasma-derived medicinal products (PDMP) such as albumin, intravenous immunoglobulin (IVIG), and clotting factors like Factor VIII and Factor IX are widely used to treat immune disorders, severe infections and bleeding conditions such as haemophilia,” he said.He added that blood centres often generate surplus plasma after meeting patient needs, which can be supplied to specialised fractionation facilities where different proteins are separated to manufacture these medicines.Dr Tiwari said PDMPs undergo multiple safety checks before reaching patients. “Donated plasma is screened for infections such as HIV, hepatitis B, hepatitis C, malaria, and syphilis, and the manufacturing process includes viral inactivation steps to ensure safety,” he said.“These medicines, known globally as plasma-derived medicinal products, have not been linked to infection transmission because of stringent testing and viral inactivation during manufacturing,” he added.Officials say repeating the same viral tests at the finished product stage creates duplication not required under global practices. The proposed amendment seeks to rationalise testing requirements while maintaining strict safety checks at the plasma screening stage.The draft rules were issued after consultation with the Drugs Technical Advisory Board, and stakeholders have been given 30 days to submit comments before the amendment is finalised.
